Track Sanjivani Paranteral Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 1.39 %
Low
140.0
High
148.0
1 Month returns: 2.10 %
Low
137.1
High
157.0
1 Year returns: -34.75 %
Low
126.0
High
268.8
3 Year CAGR: 29.84 %
Low
62.0
High
396.9
5 Year CAGR: 42.35 %
Low
22.8
High
396.9
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Sanjivani Paranteral Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Sanjivani Paranteral Ltd. Shareholding Pattern
Quarterly breakdown of Sanjivani Paranteral Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Sanjivani Paranteral Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Sanjivani Paranteral Ltd.?
The current share price of Sanjivani Paranteral Ltd. is ₹ 146.00 as of 17 Jul 2026.
What is the market capitalisation of Sanjivani Paranteral Ltd.?
The market capitalisation of Sanjivani Paranteral Ltd. stands at ₹ 179.35 Cr.
What is the PE ratio of Sanjivani Paranteral Ltd.?
The Price-to-Earnings (PE) ratio of Sanjivani Paranteral Ltd. is 26.79 as of the latest trailing twelve months data.
What is the ROE and ROCE of Sanjivani Paranteral Ltd.?
Sanjivani Paranteral Ltd. has a Return on Equity (ROE) of 15.52% and a Return on Capital Employed (ROCE) of 16.08% as per the latest financial reports.
What is the 52-week high and low of Sanjivani Paranteral Ltd.?
The 52-week high of Sanjivani Paranteral Ltd. is - and the 52-week low is -.
What is the dividend yield of Sanjivani Paranteral Ltd.?
The dividend yield of Sanjivani Paranteral Ltd. is 0.34% based on the current market price.
What is the FII and DII holding in Sanjivani Paranteral Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 1.06% and retail/public investors hold 55.02% of Sanjivani Paranteral Ltd. shares.
What sector does Sanjivani Paranteral Ltd. belong to?
Sanjivani Paranteral Ltd. operates in the Healthcare sector.
What is the beta of Sanjivani Paranteral Ltd.?
The beta of Sanjivani Paranteral Ltd. is 0.95, indicating its price volatility relative to the broader market. Over the past 1 year, Sanjivani Paranteral Ltd. has delivered an absolute return of -33.64%.
What is the RSI of Sanjivani Paranteral Ltd.?
The 14-day Relative Strength Index (RSI) of Sanjivani Paranteral Ltd. is 48.07, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Sanjivani Paranteral Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.3 as on 31 Mar 2026 and Debt to Equity increased marginally by 0.09 in the last 1 year
What is Debt to Equity?
Negative
Weak price momentum
Price Momentum score of 9.4 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term
What is Price Momentum score?
9.4 / 100
Low revenue growth and lower than median growth of industry
The company delivered moderate revenue growth of -2.04% for 12-month ended 31 Mar 2026 and the growth was 13.27 percentage points lower than median growth of industry
What is Sales growth (1Y)?
Median: 11.23
Value -2.04
-82.35114662
Low EPS growth and lower than median growth of industry
The company delivered moderate EPS growth of -17.55% for 12-month ended 31 Mar 2026 and the growth was 25.67 percentage points lower than median growth of industry
What is EPS growth (1Y)?
Company's earnings are of low quality
Earnings quality score of 28.0 indicates that the company's earnings are of low quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
28.0 / 100
Low dividend yield
The company has a low dividend yield of 0.34%
What is Dividend yield?
Neutral
Stock appears expensive but is at a discount to industry median P/E
PE TTM of 26.79 indicates that the stock is expensive on a standalone basis but discount to industry median P/E is decent at -13.24%
What is P/E Ratio?
Median: 30.88
Value 26.79
-44.893379.36
High ROE but declining trend
The company reported strong ROE of 15.52% for 12-month ended 31 Mar 2026 but ROE declined by -905 bps from 1 year ago
What is ROE (FY)?
Moderate and stable operating margin
The company reported moderate operating margin of 13.24% for 12-month ended 31 Mar 2026 and operating margin declined marginally by -63 bps from 1 year ago
What is Operating profit margin?
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.230215.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Holdings and Presence
Indices and prominent investors with a stake in this stock.
Index Presence
Sanjivani Paranteral Ltd. is not part of any tracked index.
History of Sanjivani Paranteral Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Dividend₹ 0.50/share
Record date: 19th Sep 2025Ex-date: 19th Sep 2025
Announced on: 27th May 2025
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Promoter
8.41
8.36
8.36
8.36
24.63
24.63
19.85
27.35
27.35
27.35
27.35
27.35
29.88
31.70
32.34
32.34
27.67
27.67
27.67
27.67
28.87
28.87
31.20
31.20
31.26
Indian Promoter
8.41
8.36
8.36
8.36
24.63
24.63
19.85
27.35
27.35
27.35
27.35
27.35
29.88
31.70
32.34
32.34
27.67
27.67
27.67
27.67
28.87
28.87
31.20
31.20
31.26
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
-
-
-
-
11.77
11.77
16.50
16.50
16.50
16.50
16.50
16.50
14.23
11.89
8.16
6.01
9.70
9.36
6.25
6.25
6.15
6.15
6.03
6.04
6.04
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
11.77
11.77
16.50
16.50
16.50
16.50
16.50
16.50
14.23
11.89
8.16
6.01
4.57
4.22
1.12
1.12
1.10
1.10
1.06
1.06
1.06
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
5.14
5.14
5.14
5.14
5.05
5.05
4.96
4.97
4.97
Non-Institution
91.59
91.64
91.64
91.64
63.60
63.60
63.65
56.14
56.14
56.14
56.14
56.14
55.89
56.41
59.50
61.65
62.63
62.97
66.08
66.08
64.98
64.98
62.77
62.76
62.71
Bodies Corporate
3.30
2.85
3.02
3.70
2.80
2.93
12.26
4.82
5.78
8.91
8.29
9.04
7.85
6.63
7.39
10.47
8.45
9.07
8.56
8.49
8.21
7.88
8.64
7.51
7.69
Others (incl. Retail)
No. of shareholders
88.29
5,066
88.79
5,017
88.62
4,970
87.94
4,939
60.80
4,906
60.67
4,863
51.39
4,786
51.32
4,963
50.36
4,927
47.23
4,807
47.85
4,785
47.10
4,804
48.04
4,848
49.78
4,718
52.11
4,467
51.18
4,451
54.18
4,863
53.90
6,113
57.52
6,676
57.59
6,559
56.77
6,391
57.10
6,374
54.13
6,224
55.25
5,961
55.02
5,878
Name
Month
Transaction
Holding % pre transaction
Average price
Qty.
Transaction value
ASHWANI KHEMKA
Promoter
June-2026
Market Purchase (Acquisition)
11th Jun 2026
29.60 %
₹ 140.21
17.50 k
₹ 24.54 lac
ASHWANI KHEMKA
Promoter
March-2026
Market Purchase (Acquisition)
31st Mar 2026
29.51 %
₹ 142.93
6.45 k
₹ 9.22 lac
ASHWANI KHEMKA
Promoter
March-2026
Market Purchase (Acquisition)
31st Mar 2026
29.57 %
₹ 142.68
3.64 k
₹ 5.19 lac
Company Profile
Overview of Sanjivani Paranteral Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Sanjivani Paranteral Limited is engaged in the business of manufacturing pharmaceutical products. The Company’s products include oral solids, small volume parenteral and sterile powder formula. Its product category includes antibiotic, anti-emetic, non-steroidal anti-inflammatory drugs (NSAID) and analgesic, antimalarial, calcium and vitamin, sedative, steroid, cardiovascular, anti-fibrinolytic, anti-coagulant, vasoconstrictor, inotropic agent, multivitamin, nutrition, diuretic, anti-hypertensive, and others. Its anti-biotic includes Netilmicin Sulfate, Amikacin Sulfate, and Gentamycin Sulfate. Its anti-emetic includes Ranitidine Hydrochloride, Metoclopramide, Ondansetron, and Promethazine. Its NSAID and analgesic include Acetaminophen Injection and Diclofenac Sodium Injection. Its calcium and vitamins include Methylcobalamin 500 mcg/ml and Nicotinic Acid 10 mg/ml. Its sedative includes Midazolam Hydrochloride, and Diazepam. Its diuretic includes Furosemide.
Sanjivani Paranteral Limited is engaged in the business of manufacturing pharmaceutical products. The Company’s products include oral solids, small volume parenteral and sterile powder formula. Its product category includes antibiotic, anti-emetic, non-steroidal anti-inflammatory drugs (NSAID) and a...
Key personnel
Mr. Pritesh Jain
Chief Financial Officer
Mr. Ravikumar Bogam
Chief Compliance Officer, Company Secretary
Mr. Ashwin A. KhemkaD
Executive Chairman of the Board, Managing Director